Veronica Escalante
Overview
Explore the profile of Veronica Escalante including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
96
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Escalante V, Nayak R, Noecker C, Babdor J, Spitzer M, Deutschbauer A, et al.
Mol Microbiol
. 2023 Sep;
122(3):372-386.
PMID: 37712143
Drugs intended to target mammalian cells can have broad off-target effects on the human gut microbiota with potential downstream consequences for drug efficacy and side effect profiles. Yet, despite a...
2.
Noecker C, Sanchez J, Bisanz J, Escalante V, Alexander M, Trepka K, et al.
PLoS Biol
. 2023 May;
21(5):e3002125.
PMID: 37205710
Human gut bacteria perform diverse metabolic functions with consequences for host health. The prevalent and disease-linked Actinobacterium Eggerthella lenta performs several unusual chemical transformations, but it does not metabolize sugars...
3.
Liu H, Shiver A, Price M, Carlson H, Trotter V, Chen Y, et al.
Cell Rep
. 2021 Mar;
34(9):108789.
PMID: 33657378
Harnessing the microbiota for beneficial outcomes is limited by our poor understanding of the constituent bacteria, as the functions of most of their genes are unknown. Here, we measure the...
4.
Man K, Bowman C, Braverman K, Escalante V, Tian Y, Bisanz J, et al.
Proc Natl Acad Sci U S A
. 2020 Dec;
117(50):32029-32037.
PMID: 33257580
Disease tolerance, the capacity of tissues to withstand damage caused by a stimulus without a decline in host fitness, varies across tissues, environmental conditions, and physiologic states. While disease tolerance...
5.
Borges A, Castro B, Govindarajan S, Solvik T, Escalante V, Bondy-Denomy J
Nat Microbiol
. 2020 Mar;
5(5):679-687.
PMID: 32203410
CRISPR-Cas systems are adaptive immune systems that protect bacteria from bacteriophage (phage) infection. To provide immunity, RNA-guided protein surveillance complexes recognize foreign nucleic acids, triggering their destruction by Cas nucleases....